News About: Pharm. Industry
Novo Nordisk South Korea’s CP violation, expecting ‘large-scale personnel transfers’
Novo Nordisk South Korea is having a rough time as violating the Compliance Program(CP).
According to the industry concerned on the 6th, the Novo Nordisk headquarters dispatched an external audit agency last month t...
MSD Korea’s unfair illegal actions bounced back to domestic companiesThe illegal action of a large multinational pharmaceutical company has been bounced back to domestic ones.
Particularly, in the circumstance where the Fair Trade Commission(FT...
|
Samsung Bioepis to file ‘Humira’ patent nullification lawsuit
Samsung Bioepis filed a lawsuit to nullify a patent against a global pharmaceutical company Abbvie in the U.K.
The reason for the lawsuit is that Abbvie encountering the patent expiration of ‘Humira,’ a rheumatoid ar...
While owner-like CEOs leave, ‘real owners’ come in front
Vice President Won-bae Kim(69) at Dong-A ST is the first CEO who used to be a R&D head in the pharmaceutical industry. After entering Dong-A Pharm in 1974, he has worked as a specialist in R&D for more than 40 years, ...
Green Cross starts to export tetravalent influenza vaccinesOn the 5th, Green Cross(President Eun-cheol Huh) announced acquisition of product approval of ‘GCFLU QUADRIVALENT INJ,’ a tetravalent influenza vaccine 0.5ml vial, from the Mini...
|
Listed pharmaceutical companies’ average annual salary, KRW 54.3 million
It was surveyed employees in listed pharmaceutical companies receive KRW 54 million annual salaries on average.
It was also observed the salary gap between men and women is KRW 15.8 million as estimating KRW 58 mill...
Samsung Bioepis receives positive evaluations for ‘Flixabi’ from CHMP
On the 2nd, Samsung Bioepis announced it received positive opinions from the European Medicines Agency(EMA) and the Committee for Medicinal Products for Human Use(CHMP) for its autoimmune disease treatment Flixabi.
F...
Big pharmaceutical companies’ CEOs visits to Korea are glad, yet not big deals
In this year, decision makers of global pharmaceutical companies, such as presidents and CEOs, have visited Korea in a series.
They all are from well-known pharmaceutical companies, such as Lilly, Beohringer Ingelhe...
SK Chemicals applies for sales approval of dementia treatment from US FDAA SK Chemicals’ patch-type dementia treatment will knock on the door of the U.S. market.
SK Chemicals(CEO Man-hoon Park) announced it completed application of the sales approva...
|
Listed pharmaceutical companies’ annual salary for internal directors
Listed pharmaceutical companies’ internal directors were observed to receive KRW 279 million annual salaries on average last year.
According to the ‘2015 Annual Salary of Internal Directors’ data based on business r...
